Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT03072056
Brief Summary:
* To evaluate the pharmacokinetic (PK) profile of MIN-101 and its metabolites in extensive (EM) and poor (PM) metabolizers
* To evaluate the relationship between plasma levels of MIN-101 and changes in QT/QTcF intervals
* To evaluate safety and tolerability of MIN-101.
Study:
NCT03072056
Study Brief:
Protocol Section:
NCT03072056